MP Materials Corp. <MP.N>: Barclays cuts target price to $65 from $69
MP•Related News

Gain Therapeutics names Joanne Taylor chief scientific officer, promotes Terenzio Ignoni to COO
GANX•

Moderna doses first patient in Phase 1 trial of mRNA-4200 cancer therapy in solid tumors
MRNA•

AEye to report Q2 results, host conference call and webcast
LIDR•

Ligand Pharmaceuticals Inc <LGND.O>: Benchmark Raises Target Price to $335 from $275
LGND•

EyePoint grants inducement stock options for 63,500 shares at $13.85 each
EYPT•